G. Bergers

Molecular Biology · 2000–2021

A researcher in the Science corpus: 11 papers; trusts 11 researchers and is trusted by 33 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 146 citations into it; #1,213 of 17,773 by trust here, #1,117 by citations
• Cancer Research — 79 citations into it; #180 of 1,780 by trust here, #162 by citations
• Oncology — 70 citations into it; #622 of 1,698 by trust here, #1,139 by citations
• Immunology — 38 citations into it
• Biomedical Engineering — 20 citations into it
• Immunology and Allergy — 19 citations into it
• Cellular and Molecular Neuroscience — 8 citations into it
• Neurology — 5 citations into it; #264 of 1,455 by trust here, #204 by citations

Whom G. Bergers trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. N. Ferrara
2. Holger Gerhardt
3. Rakesh K. Jain
4. J. Pollard
5. G. Semenza
6. P. Baluk
7. C. Betsholtz
8. Robert A. Gatenby
9. Steven Song
10. J. Folkman

Who trusts G. Bergers overall

1. D. Hanahan
2. J. Joyce
3. Peter Carmeliet
4. Rakesh K. Jain
5. N. Ferrara
6. R. Weinberg
7. Raghu Kalluri
8. Simone Brabletz
9. N. Sharpless
10. O. Casanovas

Papers from G. Bergers's perspective

Ordered by how strongly the researchers G. Bergers trusts endorse each paper. Same corpus, a different order for every researcher.

1. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis (Nature Cell Biology)
2. Origins of circulating endothelial cells and endothelial outgrowth from blood. (Journal of Clinical Investigation)
3. Dissecting tumour pathophysiology using intravital microscopy (Nature Reviews. Cancer)
4. Tumor angiogenesis (Advances in Cancer Research)
5. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
6. Molecular mechanisms and clinical applications of angiogenesis (Nature)
7. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. (New England Journal of Medicine)
8. Lack of Pericytes Leads to Endothelial Hyperplasia and Abnormal Vascular Morphogenesis (Journal of Cell Biology)
9. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis (Proceedings of the National Academy of Sciences of the United States of America)
10. The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development. (Developmental Biology)

Their papers

• Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis (2000) — 2,860 citations
• Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. (2003) — 1,419 citations
• Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. (2005) — 1,655 citations
• Modes of resistance to anti-angiogenic therapy (2008) — 2,895 citations
• HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. (2008) — 1,165 citations
• Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. (2009) — 2,440 citations
• The role of pericytes in blood-vessel formation and maintenance. (2005) — 1,513 citations
• The metabolism of cancer cells during metastasis (2021) — 759 citations
• Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice. (2000) — 872 citations
• Consensus guidelines for the use and interpretation of angiogenesis assays (2018) — 555 citations
• Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation (2017) — 746 citations